Clinical Trial Update: Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of ALT-100mAb in adults with moderate to severe Acute Respiratory Distress Syndrome; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• ALT-100mAb (ALT-100 monoclonal antibody)

Snippet

Sponsor: Aqualung Therapeutics Corp. | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | Status: ACTIVE_NOT_RECRUITING